Focused Issue on Controversies in Minimally Invasive Urologic Oncology

Posted On 2019-06-24 14:39:00



This focused issue on “Controversies in Minimally Invasive Urologic Oncology” is edited by Dr. Marc C. Smaldone, from Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA; and Dr. Jeffrey J. Tomaszewski, Division of Urology, Department of Surgery, MD Anderson Cancer Center at Cooper, Cooper Medical School of Rowan University, Camden, NJ, USA

Dr. Marc C. Smaldone has expertise in open, laparoscopic, and robotic surgical techniques, which allows him to tailor a specific treatment plan based on individual patient need and preferences. He also has a particular expertise in minimally invasive organ preserving and reconstructive techniques to preserve function and quality of life, including nerve-sparing prostatectomy for patients with prostate cancer and partial nephrectomy for patients with kidney cancer.

Dr. Jeffrey J. Tomaszewski received his medical degree from Sidney Kimmel Medical College. He currently is the Director of Genitourinary Oncology Program of Cooper University Health Care and is Assistant Professor of Surgery of Cooper Medical School of Rowan University.

Focused issue outline:

  1. Diffusion of new technologies and adoption of robotic technology for urologic oncologic procedures
    Bruce L Jacobs, Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  2. Comparative effectiveness of open versus robotic prostatectomy
    Simon P Kim, Center for Quality and Outcomes, Urology Institute, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
  3. Evolving techniques and optimizing functional outcomes following robotic prostatectomy (retzius sparing and partial prostatectomy)
    Daniel D Eun, Department of Urology, Temple University Hospital, Philadelphia, Pennsylvania, USA
  4. Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer
    Brian F Chapin, Department of Urology, MD Anderson Cancer Center, Houston, TX, USA
  5. Outcome and expanding indications (SEMS trial for seminoma) for robotic retroperitoneal lymph node dissection for testicular cancer
    Jeffrey J. Tomaszewski, Division of Urology, Department of Surgery, MD Anderson Cancer Center at Cooper, Cooper Medical School of Rowan University, Camden, NJ, USA
  6. Robotic renal surgery for RCC with IVC thrombus
    Marc C Smaldone, Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA
  7. Expanding the indications for retroperitoneoscopic robotic partial nephrectomy
    Alexander Kutikov, Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA
  8. Comparative effectiveness of open and robotic radical cystectomy
    Nikhil Wainganker and Reza Mehrazin, Department of Urology at the Icahn School of Medicine at Mount Sinai, New York, NY, USA
  9. Contemporary techniques and outcomes of intracorporeal urinary diversions
    Anthony T Corcoran, Department of Urology, NYU-Winthrop University, Mineola, NY, USA
  10. Role of lymph node dissection at the time of open or minimally invasive nephroureterectomy
    Jose A Karam, Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
  11. Open versus minimally invasive management for suspected adrenal cortical carcinoma
    Benjamin T. Ristau, Division of Urology, UConn Health, Farmington, CT, USA
  12. Open versus laparoscopic versus robotic inguinal lymph node dissection for penile cancer
    Andres F Correa, MD Anderson Cancer Center at Cooper, Camden, NJ, USA
  13. Robotic assisted reconstruction for complications following urologic oncologic procedures
    Ronak Gor, MD Anderson Cancer Center at Cooper, Camden, NJ, USA
  14. Using physician led quality improvement collaboratives to improve patient outcomes following robotic prostatectomy
    Serge Ginzburg, Department of Urology, Einstein Healthcare Network, Philadelphia, PA, USA
    Adam Reese, Department of Urology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
  15. Minimizing opioid consumption following robotic procedures
    Shreyas S Joshi, Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA